Physician profile
Mohammad T Hashemi
NPI 1750584355
$1,561.32
in general payments reported to CMS, 2019-2025
9 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $573 · 2022: $160 · 2023: $35.50 · 2024: $50.61 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,103.61 | 2019-2022 | |
| Smith+Nephew, INC. | $184.96 | 2022-2025 | Stravix Pl, Novostitch, Fast-Fix |
| Merz North America, INC. | $63.64 | 2019 | |
| Medical Device Business Services, INC. | $60.24 | 2019 | |
| Davol INC. | $57.42 | 2024-2025 | Arista, Arista Ah Flexitip |
| Becton, Dickinson and Company | $32.96 | 2024 | Arista Ah Flexitip |
| Bioventus LLC | $21.53 | 2025 | Exogen Ultrasound Bone Healing System |
| Cornerstone Medical Associates, INC. | $19.61 | 2023 | |
| Merck Sharp & Dohme LLC | $17.35 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Hashemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.